SEC Company Response from Alzamend Neuro, Inc. (ALZN) (CIK 0001677077) (ALZN) — Dec 6, 2016

Alzamend Neuro, Inc. (ALZN) (CIK 0001677077)
Date: Dec. 6, 2016 · CIK: 0001677077 · Accession: 0001615774-16-008732

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 024-10637

Date

December 6, 2016

Author

Not clearly detected

Form

CORRESP

Company

Alzamend Neuro, Inc. (ALZN) (CIK 0001677077)

Letter

VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Re.: Alzamend Neuro, Inc. – Request for Qualification Offering Statement on Form 1-A Filed November 14, 2016 File No. 024-10637

Dear Ms. Hayes:

We respectfully request that the above referenced Offering Statement on Form 1-A for Alzamend Neuro, Inc., a Delaware corporation, be declared qualified by the Securities and Exchange Commission at 4:30 PM Eastern Time on Thursday, December 8, 2016.

Very truly yours,
ALZAMEND NEURO, INC.

Show Raw Text

CORRESP
1
filename1.htm

Alzamend Neuro, Inc.

50 W. Broadway, 3rd Floor

Salt Lake City, UT 84101

December 6, 2016

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn.: Suzanne Hayes, Assistant Director

Re.:       Alzamend
Neuro, Inc. – Request for Qualification

Offering Statement on Form 1-A

Filed November 14, 2016

File No. 024-10637

Dear Ms. Hayes:

We respectfully request
that the above referenced Offering Statement on Form 1-A for Alzamend Neuro, Inc., a Delaware corporation, be declared qualified
by the Securities and Exchange Commission at 4:30 PM Eastern Time on Thursday, December 8, 2016.

Very truly yours,

ALZAMEND NEURO, INC.

        By: /s/ Philip Mansour

        Name: Philip Mansour

        Title: Chief Executive Officer

SecProbe.io